Yuan Tian
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Yuan Tian is currently the Chairman and Chief Executive Officer at CIFCO International Group since 2007.
Prior to this, he was the Chairman at China International Futures Co., Ltd. He also served as a Non-Executive Director at Quam Plus International Financial Ltd. from 2006 to 2008.
Additionally, he was a Director at ContraFect Corp.
and a Non-Executive Director at Ascentage Pharma Group International Co., Ltd. Dr. Tian holds a doctorate degree from Wuhan University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
CIFCO International Group
CIFCO International Group Investment ManagersFinance Provides financial advisory services | Vorstandsvorsitzender | 01.01.2007 |
| Unternehmen | Position | Ende |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Direktor/Vorstandsmitglied | 20.05.2022 |
| QUAM PLUS INTERNATIONAL FINANCIAL LIMITED | Direktor/Vorstandsmitglied | 11.09.2008 |
| CONTRAFECT CORPORATION | Direktor/Vorstandsmitglied | - |
China International Futures Co., Ltd.
China International Futures Co., Ltd. Investment Banks/BrokersFinance Provides commodities trading services | Vorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Quam Plus International Financial Ltd.
Quam Plus International Financial Ltd. Investment Banks/BrokersFinance Provides securities brokerage, financial advisory, and fund management services | Finance |
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China International Futures Co., Ltd.
China International Futures Co., Ltd. Investment Banks/BrokersFinance Provides commodities trading services | Finance |
ContraFect Corp.
ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
CIFCO International Group
CIFCO International Group Investment ManagersFinance Provides financial advisory services | Finance |
Ascentage Pharma Group International Co., Ltd.
Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen